Bausch + Lomb: The Market Is Pricing The Balance Sheet, Not The Eye-Care EngineSeeking Alpha • 08/20/26
Why Bausch Health (BHC) is a Top Momentum Stock for the Long-TermZacks Investment Research • 08/11/26
BHC Q2 Earnings Beat Estimates on Salix and Solta Growth, '26 View RaisedZacks Investment Research • 07/30/26
Bausch (BHC) Down 5.4% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 05/29/26
Bausch Health's Aesthetic Business, Solta Medical, Earns Prestigious Trademark Certification of Thermage® in ChinaPRNewsWire • 05/28/26
Bausch Health Companies Inc. (BHC) Presents at RBC Capital Markets Global Healthcare Conference 2026 TranscriptSeeking Alpha • 05/20/26
Bausch Health Companies Inc. (BHC) Presents at Barclays 30th Annual Leveraged Finance Conference 2026 TranscriptSeeking Alpha • 05/19/26
Bausch + Lomb Launches PreserVision AREDS3™ Eye Vitamins in the United StatesBusiness Wire • 05/19/26
Bausch Health to Participate in RBC Capital Markets 2026 Global Healthcare ConferencePRNewsWire • 05/13/26
Bausch Health to Participate in Barclays 30th Annual Leveraged Finance ConferencePRNewsWire • 05/12/26